HB Wealth Management, LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1911253
Atlanta, GA
Position in TEVA
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$294,518
New position
Shares Held
8,693
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#463
of 671 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HB Wealth Management, LLC holds $9,010,122 across 12 Drug Manufacturers - Specialty & Generic names. TEVA ranks #6 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
38,820 | $2,789,605 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2,331 | $1,263,005 | |
| 3 | HLN |
Haleon plc
|
133,227 | $1,243,007 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
7,323 | $1,234,218 | |
| 5 | VTRS |
Viatris Inc
|
58,985 | $936,681 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
8,693 | $294,518 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
19,136 | $277,280 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
11,108 | $273,367 |
All Filings in TEVA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $294,518 | 8,693 | Shares | Sole | 2026-07-29 | |
| No filing history on record for this holder in this stock. | ||||||